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Background: As the benefits of patient-centered care have become more widely recognized, it is important to
understand patients’ sentiments regarding aspects affecting their care. In an effort to display more sensitivity to
patient concerns, the term “disorders of sex development” (DSD) was proposed in 2006 as new nomenclature
to replace older terms that were considered to have negative connotations.
Methods: The objective of the study was to examine the views of congenital adrenal hyperplasia (CAH)
patients and their caregivers regarding the new nomenclature. The study was observational to evaluate the
views of the CAH community, and the primary endpoint was perception of the term DSD. The study was
conducted as a survey about views regarding DSD nomenclature. The survey was sent via email to eligible
subjects. Along with a short introduction explaining the term DSD, the survey was sent to eligible CAH
patients and their caregivers. 589 CAH patients or family members participated in the survey.
Results: A total of 589 responses were received (255 classical females, 104 non-classical females, 174 males,
56 not specified) (547 U.S., 42 international) (128 CAH patients, 408 parents or other family members). 70.6%
had never heard the term DSD. 71.0% disliked or strongly disliked the term DSD. 83.6% stated they did not
identify with the term DSD. 76.0% felt that the term DSD has a negative effect on the CAH community. There
was no significant difference in opinion of DSD between classical females and other CAH patients, between
US and international, between surgical and non-surgical patients, or between patients and parents. There was
no correlation with patient age.
Conclusions: Our results indicate that the majority of parents and patients with CAH are dissatisfied with the
term DSD. Our results highlight the challenges within the field of DSD to reach a consensus regarding a
sensitive topic and to bridge the gap between current medical practice and patient satisfaction. It is the
authors’ belief that reconsideration of the current nomenclature and ongoing dialogue between the medical
community and patients will eventually lead to removal of stigmatization, better management protocols, and
improved outcomes.
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Disorders of sex development (DSD) is an umbrella term
that was proposed by the International Intersex Consen-
sus Conference in 2006 to describe conditions in which
fetal development of chromosomal, gonadal, or anatomic
sex is atypical [1]. Due to concerns raised by patient
advocacy groups, the term DSD was developed to re-
place previously employed terms, such as “intersex”,* Correspondence: klin@med.cornell.edu
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unless otherwise stated.“pseudohermaphroditism”, “hermaphroditism”, “sex rever-
sal”, and other labels that were perceived by patients and
parents to have negative connotations [2-4]. A study by
Pasterski et al. (2010) found that 100% of the pediatric en-
docrinologists surveyed in Europe reported using the new
terminology [5], indicating that the medical community is
responsive to patient views and receptive to evolving ter-
minology. However, data regarding patient perception of
the new nomenclature are limited.
Examples of medical conditions included under the
term DSD are: 46,XX classical 21-hydroxylase deficiencyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gen insensitivity syndrome (partial or complete), gonadal
dysgenesis, ovotesticular DSD, and 5-alpha-reductase
deficiency. Due to the extreme rarity of many of these
conditions, 46,XX classical 21OHD CAH accounts for a
substantial portion of cases of those grouped under the
term DSD. CAH is a family of autosomal recessive enzyme
deficiencies that cause insufficient cortisol production by
the adrenal cortex; 21OHD accounts for >90% of CAH
cases. In 21OHD CAH, cortisol deficiency leads to in-
creased ACTH production and subsequent excess andro-
gen production by the adrenal cortex [6]. Females with the
classical (severe) form of CAH are born with varying de-
grees of androgenized genitalia and are included under the
term DSD. Males with 21OHD CAH and females with the
non-classical (mild) form are born without any effects on
their genitalia, thus are not included under DSD.
The new term DSD was introduced with the hope of
developing terminology that would be more sensitive to
patient views while at the same time maintaining scien-
tific and medical integrity. A small study in 2010 evalu-
ated acceptability of the new terminology among parents
and health professionals; however, the sample included
only 19 parents of children with a DSD [7]. As the term
DSD has become more widely utilized in the literature,
internet, research proposals, and patient care clinics, par-
ents and patients with CAH have expressed their concerns
to the authors about the potential misconceptions that
could arise from having CAH linked to the words “sex”
and “disorder”. It is important, therefore, to understand
the new nomenclature’s perceived connotation and its im-
pact on patients and families.
The goal of the study was to determine perception
of the CAH community towards the new term DSD.
To achieve this objective, the authors surveyed CAH pa-
tients and their caregivers. Subjects were recruited through
CARES (Congenital Adrenal hyperplasia Research
Education and Support) Foundation, a U.S.-based (with
international representation) patient advocacy group for
CAH patients and their families.
Methods
Subjects
Potential subjects were identified through CARES Foundation’s
online database, which includes email addresses for all
registered patients and families. Inclusion criteria were: 1)
CAH patient or family member of a patient with CAH, 2)
at least 18 years of age, and 3) able to read and understand
English. Email contacts were excluded if they were incom-
plete, duplicated, or from the same household.
Survey
A short introduction explaining the term DSD along
with a questionnaire regarding nomenclature were sentvia email using Survey Monkey; only one survey was sent
per household. Survey responses were anonymous. Ap-
proval was obtained from the Institutional Review Board
at Weill Cornell Medical Center.
Questions from the survey included:
1. Have you ever heard the term “disorder of sex
development” or DSD?
2. When is the first time you heard the term DSD used
to describe CAH?
3. What do you think of the term DSD?
4. Do you identify with the use of the term DSD as a
CAH parent or patient?
5. How do you feel about clinics that monitor patients
with CAH and other conditions being called DSD
clinics?
6. Would you seek care for yourself or your child at a
clinic or center that used the term DSD to encompass
CAH?
7. Would you participate in research studies using the
term DSD instead of CAH?
8. In your opinion, what effect does using the term DSD
have on the CAH community?
9. How do you feel about the term “ambiguous genitalia”
to describe genitalia that are not definitively male or
female?
10.If you would rather have an alternate way of
describing genitalia at birth that are not definitively
male or female, what term(s) do you prefer?Statistical analysis
The primary endpoint variable was opinion regarding
the term DSD (5 point scale: 1 = strongly dislike; 2 = dis-
like; 3 = neutral; 4 = don’t mind; 5 = like). A secondary
endpoint variable was opinion regarding the term “am-
biguous genitalia” (5 point scale as above). A student’s t-
test was used for comparisons of mean opinion scores
between two groups (classical females vs. other CAH pa-
tients; parents vs. patients). A Welch’s t-test was used
for comparisons between U.S. vs non-U.S and between
surgical vs non-surgical classical females. Analysis using
Pearson’s correlation coefficient was performed to assess
the relationship between patient age and opinion. A chi
square test of independence was performed to examine
differences between groups with categorical variables
(yes/no). A result was considered to be statistically sig-
nificant if p <0.05.Results
Participants
The survey was sent via email to 2032 eligible U.S. CAH
families and 254 eligible international CAH families. A
total of 547 U.S. responses and 42 non-U.S. responses
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these numbers were excluded from statistical analysis.
Most of the survey takers were parents of CAH pa-
tients. Of 534 people who described their relationship to
the patient, 128 (24.0%) were CAH patients, 374 (70.0%)
were parents, and 32 (6.0%) were other relatives of pa-
tients, e.g. grandparent, aunt/uncle, or sibling. Sixty-six
(12.4%) were parents of more than one affected child, 10
(1.9%) were parents of affected children and patients
themselves, and 4 (0.7%) were patients who had affected
siblings.
The majority of patients had classical CAH: 406
(76.5%) patients had classical CAH, and 125 (23.5%) had
non-classical CAH. The mean patient age at the time of
the survey was 17.6 ± 15.5 years (range 2 months to
70 years). Median patient age was 12 years (interquartile
range = 6 to 26 years).
Out of 537 responses, 359 (66.9%) patients were fe-
male (255 classical; 104 non-classical), 174 (32.4%) were
male, and 4 (0.7%) answered “other”, e.g. more than one
affected or “not relevant.”
Of the 255 classical female patients, 30 neither had
nor planned to have genital surgery (non-surgical); 3 had
received prenatal treatment. 223 classical females either
had genital surgery or planned to have surgery (surgical).Awareness of the term DSD
Of 581 survey takers, 149 (25.6%) had previously heard
the term DSD, 410 (70.6%) had never heard the term be-
fore, and 22 (3.8%) were not sure. Compared to U.S. sur-
vey takers, non-U.S. survey takers were more likely to
have heard the term DSD, (24.1% vs. 45.2% respectively,
Х2 = 9.57, p <0.01) (see Figure 1a). Of those who were
previously aware of the term, 80 (53.7%) heard it when
researching the internet, 29 (19.4%) at a conference, 27
(18.1%) when their child was born, and 6 (4.0%) at the
first post-diagnosis appointment.Opinion regarding DSD nomenclature
When asked what they think of the term DSD, 196
(33.7%) strongly dislike it, 217 (37.3%) dislike it, 111
(19.1%) are neutral, 52 (8.9%) don’t mind it, and 6 (1.0%)
like it (see Figure 1b). There was no correlation between
patient age and opinion regarding the term DSD: r =
0.02, p = 0.64.
There was no statistical difference in mean opinion
scores between classical females and other CAH patients,
between parents/family members and patients, between
U.S. and non-U.S. participants, or between surgical and
non-surgical classical females (see Table 1).
Of 574 responses, 480 (83.6%) said they do not identify
with the term DSD as either a CAH parent or patient;
94 (16.4%) said they identify with the term DSD.Views on clinics/centers and research using the term DSD
When asked how they feel about clinics that monitor CAH
patients being called DSD clinics, 282 (51.0%) strongly
disagree, 128 (23.1%) somewhat disagree, 100 (18.1%) are
neutral, 29 (5.2%) somewhat agree, and 14 (2.5%) strongly
agree (see Figure 1c).
When asked if they would seek care at a clinic or cen-
ter that used the term DSD to encompass CAH, 286
(49.5%) said No, 198 (34.2%) said Maybe, and 94 (16.3%)
said Yes.
Regarding participation in research studies that use
the term DSD instead of CAH, 310 (53.2%) said No, 200
(34.3%) said Maybe, and 73 (12.5%) said Yes.
Impact of DSD on the CAH community
Out of 580 responses, 441 (76.0%) believe that using the
term DSD has a negative effect on the CAH community;
105 (18.1%) are not sure; 18 (3.1%) feel it has a positive
effect; 16 (2.8%) feel that it has no effect (see Figure 2).
Opinion regarding the term ambiguous genitalia
When asked what they think of the term ambiguous geni-
talia, 52 (9.0%) strongly dislike it, 95 (16.4%) dislike it, 168
(29.0%) are neutral, 228 (39.4%) don’t mind it, and 36
(6.2%) like it (see Figure 3a). The mean opinion score of
classical females (3.0 ± 1.1) was significantly lower than
the mean opinion score of other CAH patients (3.4 ± 0.9),
p <0.01. There was no significant difference between par-
ents and patients, between U.S. and non-U.S., or between
surgical and non-surgical classical females (see Table 1).
There was no correlation between patient age and
opinion regarding the term ambiguous genitalia: r = 0.01;
p = 0.82.
There were 486 participants who selected alternate
terms to describe genitalia at birth that are not defini-
tively male or female (see Figure 3b), with the highest
percentage (35.4%) preferring nontypical genitalia.
Discussion
This report describes the views of CAH patients and
their caregivers regarding DSD nomenclature. Although
the term was developed with the goal of being more sensi-
tive to affected individuals, those represented in this sur-
vey feel that the term has a negative impact on the CAH
community. As the benefits of patient-centered care are
becoming more widely recognized [8-10], it is important
to understand patients’ thoughts and sentiments regarding
aspects affecting their care. This study is of great signifi-
cance because it provides the first comprehensive survey
revealing the perception of CAH patients towards an ex-
tremely sensitive topic.
In the earlier study by Davies et al. (2010), nearly 95% of
parents preferred the new term over “intersex”, but only
37% considered DSD to be an acceptable replacement
Figure 1 Response percentages regarding DSD. a: Have you ever heard the term “disorder of sexual development” or DSD? b: What do you
think of the term DSD? c: How do you feel about clinics that monitor CAH patients being called DSD clinics? Classical F = female patients with
classical CAH; NC F +M = female patients with non-classical CAH and male patients with any form of CAH. US = United States; Intl = International.
Parent = survey completed by the parent or family member of CAH patient; Self = survey completed by the CAH patient
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participants had a favorable opinion of the term DSD,
whereas over 70% disliked or strongly disliked it. Thefinding that only 26% had heard the term DSD prior to
the survey (and only a small minority first heard it from a
medical professional) may suggest that health care
Table 1 Opinion scores regarding the terms “DSD” and “ambiguous genitalia”
What do you think of the term DSD? Classical females vs Other CAH 2.0 ± 1.0 vs 2.1 ± 0.9
Parents vs Patients 2.0 ± 1.0 vs 2.2 ± 1.0
US vs non-US patients 2.0 ± 1.0 vs 2.2 ± 1.0
Surgical vs non-surgical 2.0 ± 1.0 vs 2.1 ± 1.2
What do you think of the term ambiguous genitalia? Classical females vs Other CAH 3.0 ± 1.1 vs 3.4 + 0.9*
Parents vs Patients 3.2 ± 1.1 vs 3.1 ± 1.0
US vs non-US patients 3.2 ± 1.1 vs 3.0 ± 1.2
Surgical vs non-surgical 3.0 + 1.1 vs 3.0 + 1.2
1 = Strong dislike; 2 = Dislike; 3 = Neutral; 4 = Don’t mind; 5 = Like.
Results are expressed as mean ± SD.
*p <0.01.
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nicating with their CAH patients. Furthermore, most of
the respondents who were already aware of the term
learned about it through the internet; this issue warrants
further exploration because unguided internet searches
could potentially increase rates of misinformation and
amplify feelings of stigmatization.
Over 75% of respondents felt that the term DSD has a
negative effect on the CAH community. Review of op-
tional comments from the survey showed that many
respondents find the term DSD to be misleading and
potentially stigmatizing. They expressed concern that
friends and others who see the diagnosis of CAH as-
sociated with the term DSD might misunderstand and
think they have a sexual disorder. Words used by sur-
vey participants in response to the term DSD include
horrific, offensive, humiliating, confusing, embarrassing,Figure 2 In your opinion, what effect does using the term DSD havetraumatizing, derogatory, demeaning, alarming, and sen-
sationalistic. The words “stigma” and “negative” were
used over 100 times in comments by participants. Others
remarked that calling CAH a DSD detracts from the more
important medical issues related to adrenal insufficiency,
especially since the term DSD refers only to females with
classical CAH and not to patients with non-classical CAH
or males.
Although the term DSD refers only to females with
the classical form of CAH, males and non-classical pa-
tients are often mistakenly linked to the term. Because
many patients have commented that the term DSD seg-
regates the CAH community, the authors felt it was im-
portant to maintain cohesiveness and survey the CAH
community as a whole. The results show that the non-
DSD patients feel just as strongly about the term as clas-
sical females. There was no difference in opinion scoreson the CAH community? (n = 580).
Figure 3 Response percentages regarding ambiguous genitalia. a: How do you feel about the term ‘ambiguous’ to describe genitalia at
birth that are not definitively male or female? b: If you would rather have an alternate way of describing genitalia at birth that are not definitively
male or female, what term(s) do you prefer? Please check all that apply.
Lin-Su et al. International Journal of Pediatric Endocrinology  (2015) 2015:9 Page 6 of 7between classical females and non-DSD patients with
CAH. The average scores for the two groups were 2.0 and
2.1, scores that correspond with “dislike” (Table 1). Like-
wise, there was no difference between U.S. and non-U.S.
respondents, between surgical and non-surgical patients,
or between adult patients who took the survey themselves
and parents who took the survey. These results indicate a
consistent attitude across different subgroups within the
CAH community.
Within the same context, most CAH patients prefer not
to be associated with the term DSD. In fact, more than
half of those surveyed said they would not choose to re-
ceive care from centers or participate in research studies
that use the term DSD. As a consequence, the current no-
menclature may pose a barrier for certain patients to seek
expert care in a specialized DSD center or to participate
in related research.As the response rate from those surveyed was only 29%,
the results from this survey are not necessarily representa-
tive of all patients with 21OHD nor can they be extrapolated
to other conditions under DSD. Further investigation into
the views of other patient populations under DSD would
augment our understanding of how this nomenclature is
perceived. It would also be worthwhile to survey medical
professionals to determine whether they accept the new ter-
minology and use it to communicate with their patients.
Another consideration when interpreting these results
is the potential for self-selection bias; it is possible that
only patients and parents who already had negative feel-
ings about the nomenclature participated in the survey.
However, the majority of respondents had never heard
the term DSD prior to this survey; hence, the results
seem to reflect unbiased initial reactions rather than pre-
conceived notions.
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This study provides the first comprehensive survey re-
vealing the perception of CAH patients towards an ex-
tremely sensitive topic. Evaluation of the views of nearly
600 CAH patients and parents indicates that the major-
ity are dissatisfied with the term DSD. As the term has
become more widely utilized in the literature, internet,
research proposals and patient care centers, it is import-
ant to consider the impact of this nomenclature on af-
fected individuals and families. Our results highlight the
challenges within the field of DSD to reach a consensus
regarding a sensitive topic and to bridge the gap between
current medical practice and patient satisfaction. It is
the authors’ belief that reconsideration of the current
nomenclature and ongoing dialogue between the med-
ical community and patients will eventually lead to re-
moval of stigmatization, better management protocols and
improved outcomes.
Abbreviations
DSD: Disorder(s) of sex development; CAH: Congenital adrenal hyperplasia;
21OHD: 21-hydroxylase deficiency; CARES: Congenital Adrenal hyperplasia
Research Education and Support.
Competing interests
Please note that Dr. Karen Lin-Su is the Medical Director of CARES
Foundation, and Drs. Lekarev, Poppas and Vogiatzi serve on its voluntary
Medical Advisory Board. Weill-Cornell Medical Center is also a
CARES-appointed Comprehensive Care Center for CAH.
Authors’ contributions
KLS: study conception and design, analysis and interpretation of data, major
draft and revisions of the manuscript, design of tables and figures. OL:
contributed to drafting and revising the manuscript, analysis and
interpretation of data. DP: study conception and design, analysis and
interpretation of data, contributed to drafting and revising the manuscript.
MGV: study conception and design, analysis and interpretation of data,
contributed to drafting and revising the manuscript. All authors read and
approved the final manuscript.
Authors’ information
Dr. Karen Lin-Su, MD is an Clinical Associate Professor of Pediatrics in
the Division of Pediatric Endocrinology and Metabolism, Weill Cornell
Medical College. She also serves as the Medical Director for the CARES
Foundation. Dr. Lin-Su is a well-known and respected expert in the area
of Congenital Adrenal Hyperplasia and DSD and has published widely
on the subject in several peer-reviewed journals.
Dr. Oksana Lekarev, DO is an Assistant Professor of Pediatrics in the Division
of Pediatric Endocrinology and Metabolism, Weill Cornell Medical College.
She is also the Associate Medical Director of the Comprehensive Center for
Congenital Adrenal Hyperplasia at New-York Presbyterian Hospital Weill
Cornell Medical Center. She has published widely on the subject of CAH and
DSD in peer-reviewed journals.
Dr. Dix P. Poppas, M.D. is Professor and Chief of the Institute for Pediatric
Urology at the Komansky Center for Children’s Health of New York
-Presbyterian Hosptial Weill Cornell Medical Center. He is the Richard Rodgers
Professor of Pediatric Urology in the James Buchanan Brady Department of
Urology at Weill Cornell Medical College. He serves at the Surgical Director
of the Comprehensive Center for Congenital Adrenal Hyperplasia at Weill
Cornell Medical Center. Dr. Poppas has extensive surgical and clinical experience
in taking care of a large number of patients with CAH and DSD; he has
published and lectured widely on the subject.
Dr. Maria G. Vogiatzi, MD is the Harold and Percy Uris Associate Professor of
Pediatric Endocrinology and Metabolism. Weill Cornell Medical College. She
is also the Medical Director of the Comprehensive Center for Congenital
Adrenal Hyperplasia at New-York Presbyterian Hospital Weill Cornell MedicalCenter. Dr. Vogiatzi is a well-known and respected expert in the area of
Congenital Adrenal Hyperplasia and DSD and has lectured and published
widely on the subject in several peer-reviewed journals.
Acknowledgements
The authors would like to recognize Dina Matos, Karen Fountain, and
Deborah Brown from CARES Foundation and Kerlly Bernabe from the
Department of Pediatric Urology, Weill Cornell Medical Center for their
assistance.
Author details
1Department of Pediatric Endocrinology, Weill Cornell Medical Center, 505
East 70th Street, 3rd floor, New York, NY 10021, USA. 2Department of
Pediatric Urology, Weill Cornell Medical Center, 525 East 68th Street, Suite
F-943, New York, NY 10065, USA.
Received: 28 October 2014 Accepted: 25 January 2015
References
1. Houk CP, Hughes IA, Ahmed SF, Lee PA, Writing Committee for the
International Intersex Consensus Conference P. Summary of consensus
statement on intersex disorders and their management. International
Intersex Consensus Conference. Pediatrics. 2006;118(2):753–7.
2. Hughes IA, Houk C, Ahmed SF, Lee PA, Group LC, Group EC. Consensus
statement on management of intersex disorders. Arch Dis Child.
2006;91(7):554–63.
3. Lee PA, Houk CP, Ahmed SF, Hughes IA, International Consensus
Conference on Intersex organized by the Lawson Wilkins Pediatric
Endocrine S, the European Society for Paediatric E. Consensus statement on
management of intersex disorders. International Consensus Conference on
Intersex. Pediatrics. 2006;118(2):e488–500.
4. Hughes IA. Disorders of sex development: a new definition and
classification. Best Pract Res Clin Endocrinol Metab. 2008;22(1):119–34.
5. Pasterski V, Prentice P, Hughes IA. Consequences of the Chicago consensus
on disorders of sex development (DSD): current practices in Europe. Arch
Dis Child. 2010;95(8):618–23.
6. Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital
adrenal hyperplasia. Pediatr Clin North Am. 2011;58(5):1281–300. xii.
7. Davies JH, Knight EJ, Savage A, Brown J, Malone PS. Evaluation of
terminology used to describe disorders of sex development. J Pediatr Urol.
2011;7(4):412–5.
8. Mohammed K, Nolan MB, Rajjo T, Shah ND, Prokop LJ, Varkey P, Marad MJ.
Creating a Patient-Centered Health Care Delivery System: A Systematic
Review of Health Care Quality From the Patient Perspective. Am J Med
Qual. E-published ahead of print on July 14, 2014
9. Rosenthal TC. The medical home: growing evidence to support a new
approach to primary care. J Am Board Fam Med. 2008;21(5):427–40.
10. Strickland B, McPherson M, Weissman G, van Dyck P, Huang ZJ, Newacheck P.
Access to the medical home: results of the National Survey of Children with
Special Health Care Needs. Pediatrics. 2004;113(5 Suppl):1485–92.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
